Driven Brands Holdings Inc. (DRVN) Q1 2022 Earnings Call Transcript
DRVN earnings call for the period ending March 31, 2022.
Stay updated with breaking news from Mike Macaluso. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
DRVN earnings call for the period ending March 31, 2022.
ENGLEWOOD, CO, November 22, 2021 – Ampio Pharmaceuticals (NYSE American: AMPE), a biopharmaceutical company focused on the advancement of immunomodulatory therapies for prevalent inflammatory conditions, today announced that Mike Macaluso is taking a one-year medical leave of absence from his role as Chairman and CEO, effective immediat
/PRNewswire/ -- Ampio Pharmaceuticals (NYSE American: AMPE), a biopharmaceutical company focused on the advancement of immunomodulatory therapies for prevalent...
/PRNewswire/ -- Ampio Pharmaceuticals (NYSE American: AMPE), a biopharmaceutical company focused on the advancement of immunomodulatory therapies for prevalent...
Operator Thank you, and welcome to the Ampio Pharmaceuticals 2020 earnings results and corporate update webinar. As a reminder, this call is being recorded [Operator instructions] At this time, I would like to turn the call over to Mr. Dan Stokely. Dan, please go ahead. Dan Stokely -- Executive Vice President and. Chief Financial Officer Yes. Thank you very much, and hope everyone's having a great day. It's our pleasure, myself and the rest of the Ampio executive management team, to be present today, and we'd like to thank each one of you for attending our fourth-quarter 2020 financial resul...